NEW YORK — In an effort to keep reining in the pandemic, the Biden administration will invest $1 billion to quadruple the national supply of at-home COVID-19 tests by December. In addition, it is expanding the number of free community-based test sites to 30,000 nationwide, including 20,000 in pharmacies. The White House’s announcement of the
DEERFIELD, Ill. — Walgreens Boots Alliance has filled two key executive leadership positions, the company said on Tuesday. Holly May was appointed executive vice president and global chief human resources officer and Anita Allemand was appointed chief transformation and integration officer. May and Allemand will both report to WBA CEO Roz Brewer, as members of
The pandemic has brought — in addition to peril — promise for pharmacy operators who have become central to testing and vaccination efforts. The impact of the crisis on pharmacy’s present and future, among other topics, was explored during a Chain Drug Review roundtable held virtually in conjunction with the NACDS Total Store Expo. Woldt:
CINCINNATI — The Kroger Co. released on Wednesday its 2021 Environmental, Social and Governance (ESG) report, sharing its new long-term ESG strategy and framework to benefit people and the planet, and to help create a more resilient, equitable food system for tomorrow. “As a grocery retailer, Kroger is committed to advancing positive impacts for people
WEST DES MOINES, Iowa — Dr. Daniel Fick has been named chief medical officer of Hy-Vee Inc., a new position for the company. He will help oversee all of the grocer’s existing health and medical initiatives and the development of new services and offerings to improve the wellness of Hy-Vee’s customers and employees. Fick comes
Among the many changes wrought by the pandemic has been the heightened focus on diabetes management, given the increased risks to people with the condition. The implications for diabetes care from mass vaccinations and the waning of COVID-19 are discussed on the following pages by chain drug retailers and diabetes product suppliers. CDR: With so
HYDERBAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratoriesannounced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial approved by the U.S. Food and Drug Administration (USFDA). “We are pleased to bring this important product to market at this time,” says Marc
WASHINGTON — The CRN Foundation today announced the launch of Vitamin D & Me!, a consumer education website on vitamin D and COVID-19. Vitamin D & Me! shares research, expert video interviews, news, and education in a user-friendly format and focuses on U.S. consumers ages 55+. “Most people don’t have time to keep up with
CHARLOTTE, N.C. — cbdMD, Inc., one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has received the prestigious U.S. Hemp Authority™ Certification (USHA). The certification signifies the Company’s efforts to provide a high-quality, trustworthy product and grants the right to use the Certified Seal of the U.S.
You can read the full April 26 print issue of Chain Drug Review in its entirety, along with years of archives. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!
NEW YORK — Now that more Americans are getting vaccinated in the race to build up enough herd immunity to beat the pandemic, questions are mounting as to how long the protection from those shots will last. Along with the unknown duration of immunity the shots offer, there’s also the worry of emerging variants that
PISCATAWAY, N.J. — Camber Pharmaceuticals is pleased to announce that it has launched Vigabatrin for Oral Solution, which is the generic version of Sabril. Vigabatrin for Oral Solution is used in combination with other medications to treat seizure disorders. Vigabatrin for Oral Solution is available from Camber in 500mg- 50 packet cartons. Camber Pharmaceuticals is a fully
ARLINGTON, Va. – FMI – The Food Industry Association released on Thursday the following statement from chief food and product safety officer Hilary Thesmar, regarding the U.S. Food and Drug Administration’s (FDA) release of a comprehensive plan to outline how the agency will approach heavy metal action levels in baby food. Dr. Thesmar said: “As the
You can read the full April 5 print issue of Chain Drug Review in its entirety, along with years of archives. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!